Herpes Zoster Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Herpes Zoster Clinical Trials Market Report Overview
The herpes zoster (shingles) clinical trial market research report provides an overview of the herpes zoster (shingles) clinical trials scenario. The report provides top-line data relating to the clinical trials on herpes zoster (shingles). It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Herpes Zoster Clinical Trials Market Segmentation by Regions and Countries
The key regions in the herpes zoster clinical trials market are Asia-Pacific, North America, Europe, South & Central America, and the Middle East & Africa. Of all the clinical trials conducted on herpes zoster (shingles), as of January 2023, more than 45% of the clinical trials were conducted in Asia-Pacific, followed by North America.
In a country-wise analysis, as of January 2023, China has the highest number of herpes zoster clinical trials, followed by the US, South Korea, Japan, Canada, Germany, the UK, Spain, Russia, and France.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Canada has the highest proportion of herpes zoster (shingles) to infectious disease clinical trials as of January 2023. Out of all the clinical trials conducted in the G7 countries, the majority were the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, China has the highest proportion of herpes zoster (shingles) to infectious disease clinical trials as of January 2023. Also, most of the clinical trials were conducted in China.
Herpes Zoster Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the herpes zoster clinical trials market, download a free report sample
Herpes Zoster Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the herpes zoster clinical trials market are institution, company, and the government. Out of them, the company sponsor type dominates the market, followed by institution.
Herpes Zoster Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the herpes zoster clinical trials market, download a free report sample
Herpes Zoster Clinical Trials Market - Competitive Landscape
Some of the leading sponsors in the herpes zoster clinical trials market are GSK plc, Merck & Co Inc, Astellas Pharma Inc, China National Biotec Group, Maruho Co Ltd, Hepion Pharmaceuticals Inc, Pfizer Inc, Hammersmith Medicines Research Ltd, and Acorda Therapeutics Inc. GSK plc has conducted the highest number of herpes zoster clinical trials and is followed by Merck & Co Inc and Astellas Pharma Inc.
Herpes Zoster Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading players in the herpes zoster clinical trials market, download a free report sample
Herpes Zoster Clinical Trials Market Report Overview
Key Regions | Asia-Pacific, North America, Europe, South & Central America, and Middle East & Africa |
Key Countries | China, The US, South Korea, Japan, Canada, Germany, the UK, Spain, Russia, and France |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | GSK plc, Merck & Co Inc, Astellas Pharma Inc, China National Biotec Group, Maruho Co Ltd, Hepion Pharmaceuticals Inc, Pfizer Inc, Hammersmith Medicines Research Ltd, and Acorda Therapeutics Inc |
Segments Covered in the Report
Herpes Zoster Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- North America
- Europe
- Middle East & Africa
- South & Central America
Herpes Zoster Clinical Trials Country Outlook (2023)
- China
- The US
- South Korea
- Japan
- Canada
- Germany
- The UK
- Spain
- Russia
- France
Herpes Zoster Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end-point status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with reasons for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Merck & Co Inc
Astellas Pharma Inc
China National Biotec Group
Maruho Co Ltd
Hepion Pharmaceuticals Inc
Pfizer Inc
Hammersmith Medicines Research Ltd
Acorda Therapeutics Inc
NeurogesX, Inc. (Inactive)
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key regions in the herpes zoster clinical trials market?
The key regions in the herpes zoster clinical trials market are Asia-Pacific, North America, Europe, South & Central America, and the Middle East & Africa.
-
Which are the key countries in the herpes zoster clinical trials market?
The key countries in the herpes zoster clinical trials market are China, the US, South Korea, Japan, Canada, Germany, the UK, Spain, Russia, and France.
-
What are the key sponsor types in the herpes zoster clinical trials market?
The key sponsor types in the herpes zoster clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the herpes zoster clinical trials market?
Some of the leading sponsors in the herpes zoster clinical trials market are GSK plc, Merck & Co Inc, Astellas Pharma Inc, China National Biotec Group, Maruho Co Ltd, Hepion Pharmaceuticals Inc, Pfizer Inc, Hammersmith Medicines Research Ltd, and Acorda Therapeutics Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.